Research Papers

25 of 33 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Survival Benefit of Primary Tumor Resection Combined With Chemotherapy in Patients With Unresectable Colorectal Mucinou…
Liao SW; Zhan JQ; Liu CT; Yu HT; Wen MJ.
Am J Clin Oncol (Unknown)
Published: 2023
2/6 Transparent
Characteristics Associated With Survival in Surgically Nonresected Pancreatic Adenocarcinoma in the Military Health Sys…
Eaglehouse YL; Darmon S; Gage MM; Shriver CD; Zhu K.
Am J Clin Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Management Strategies and Outcomes in Primary Liver Angiosarcoma.
Ramakrishnan N; Mokhtari R; Charville GW; Bui N; Ganjoo K.
Am J Clin Oncol (Unknown)
Published: 2023
2/6 Transparent
Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcin…
Ding Q; Wang K; Li Y; Peng P; Zhang D; Chang D; Wang W; Ren L; Tang F; Li Z.
Am J Clin Oncol (Unknown)
Published: 2023
2/6 Transparent
Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Prim…
Chan JK; Liu J; Song J; Xiang C; Wu E; Kalilani L; Hurteau JA; Thaker PH.
Am J Clin Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Efficacy and Safety of Pazopanib Plus Chemotherapy in Treating Recurrent or Persistent Ovarian Cancer: A Systematic…
Zhang Y; Fang H; Wang X; Wang H; Pan G; Chen J.
Am J Clin Oncol (Unknown)
Published: 2023
2/6 Transparent
The Impact of Concomitant Proton Pump Inhibitors Therapy on Clinical Outcome of Cancer Patients Treated With Immune Che…
Cao X; Wang Y; Huang W; Li P; Guo C; Li Y.
Am J Clin Oncol (Unknown)
Published: 2023
3/6 Transparent
Registered
Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategie…
Lai J; Yang S; Lin Z; Huang W; Li X; Li R; Tan J; Wang W.
Am J Clin Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prognostic Value of the Cutoffs for HALP in Endometrial Cancer.
Wang J; Jiang P; Huang Y; Tu Y; Zhou Q; Li N; Kong W; Yuan R.
Am J Clin Oncol (Unknown)
Published: 2023
2/6 Transparent
Preliminary Analysis of Cervical Cancer Immunotherapy.
Ma Z; Zou X; Yan Z; Chen C; Chen Y; Fu A.
Am J Clin Oncol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Factors Associated With Lymph Node Yield and Effects of Lymph Node Density on Survival of Patients With Pulmonary Sarco…
Huang L; Huang T; Li L; Feng A; He N; Li S; Lyu J.
Am J Clin Oncol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing…
Kaakour D; Hagopian G; Lee S; Lee FC.
Am J Clin Oncol (Unknown)
Published: 2022
2/6 Transparent
Clinical Significance of Transient Asymptomatic Elevations in Aminotransferase (TAEAT) in Oncology.
Lewis JH; Khaldoyanidi SK; Britten CD; Wei AH; Subklewe M.
Am J Clin Oncol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Effect of Somatosensory Interaction Transcutaneous Electrical Acupoint Stimulation on Cancer-related Fatigue and Immuni…
Shu J; Ren W; Chen S; Li L; Zhu H; Jin A.
Am J Clin Oncol (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
A Proposal to Modify the 8th IASLC System: Is it Suitable for T4N2M0 Lung Adenocarcinoma to Be Placed in Stage IIIB?
Ruan T; Jiang P; Li C; Pan G; Zhou X.
Am J Clin Oncol (Unknown)
Published: 2022
2/6 Transparent
Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung …
Dong S; Liang J; Zhai W; Yu Z.
Am J Clin Oncol (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Cancer Management During the COVID-19 Pandemic in the United States: Results From a National Physician Cross-sectional …
Hui JYC; Yuan J; Teoh D; Thomaier L; Jewett P; Beckwith H; Parsons H; Lou E; Blaes AH; Vogel RI.
Am J Clin Oncol (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Definitive Radiation Treatment Patterns and Outcomes for Low and Intermediate Risk Prostate Cancer Patients: A Cross-Co…
Asamoah FA; Yarney J; Awasthi S; Vanderpuye V; Dadzie MA; Fink A; Naghavi AO; Abrahams A; Mensah JE; Sasu E; Tagoe SN; Dhillon J; Johnstone PAS; Yamoah K.
Am J Clin Oncol (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer.
Koustas E; Sarantis P; Theoharis S; Saetta AA; Chatziandreou I; Kyriakopoulou G; Giannopoulou I; Michelli M; Schizas D; Papavassiliou AG; Karamouzis MV.
Am J Clin Oncol (Unknown)
Published: 2019
1/6 Transparent
Surgical, Urinary, and Survival Outcomes of Nerve-sparing Versus Traditional Radical Hysterectomy: A Retrospective Coho…
Li L; Ma S; Tan X; Zhong S; Wu M.
Am J Clin Oncol (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Small Cell Carcinoma of the Esophagus: A Nationwide Analysis of Treatment and Outcome at Patient Level in Locoregional …
Jeene PM; Geijsen ED; Muijs CT; Rozema T; Aleman BMP; Muller K; Baas JM; Nuyttens JJ; Wouterse S; Braam PM; Oppedijk V; Ceha HM; Cnossen J; Spruit P; Bongers EM; Berbée M; Mook S; Hulshof MCCM.
Am J Clin Oncol (Unknown)
Published: 2019
1/6 Transparent
Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer: Practical Management Issues for Patient Sel…
Den RB; George D; Pieczonka C; McNamara M.
Am J Clin Oncol (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Phase II Study of Adjuvant Chemoradiotherapy Using Docetaxel/Cisplatin/5-Fluorouracil Before and After Intensity-modula…
Liu Y; Zhao G; Xu Y; Zhang T; Chen Z; Yan G; Tu W; Hu Y; Chen Y; He X; Li X; Chen H; Yao S; Hu Z; Chen X; Chen T.
Am J Clin Oncol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab.
Meredith RF; Torgue JJ; Rozgaja TA; Banaga EP; Bunch PW; Alvarez RD; Straughn JM; Dobelbower MC; Lowy AM.
Am J Clin Oncol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy.
Venetis MK; MacGeorge EL; Baptiste DF; Mouton A; Friley LB; Pastor R; Hatten K; Lagoo J; Bowling MW; Clare SE.
Am J Clin Oncol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared